510(k) Report

510(k) · Cleared

Cleared

Solcart B

K072760510(k) TraditionalCleared Jan 29, 2008123-day reviewClass II21 CFR 876.5820

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

B. Braun Medizintechnologie GmbH · KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder)

Cleared on Jan 29, 2008 as substantially equivalent to K013724 (Gambro Renal Products, 2002) after a 123-day review. Its family tree reaches back 2 generations to 1987. 2 later devices descend from it.

Decided
Jan 29, 2008
Review
123 days
Class
Class II
Product code
KPO
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K873155 (1987). 3 ancestors in all. 2 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1994: 1 other ancestor2022: 1 descendant cleared2011: 1 descendant clearedK873155 · Gambro Bicart System · Gambro, Inc. · 1987K013724 · Bicart · Gambro Renal Products · 20021990200020102020
Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor 1 generation forward: 2 descendants K013724 · Bicart · Gambro Renal Products · 2002K873155 · Gambro Bicart System · Gambro, Inc. · 19870
  1. Root · 2 generations backK873155 Gambro Bicart SystemGambro, Inc. · 1987
  2. 1 generation backK013724 BicartGambro Renal Products · 2002
  3. This deviceK072760 Solcart BB. Braun Medizintechnologie GmbH · 2008
  4. Descendant · cites it directly · 1 of its ownK102194 Solcart BB. Braun Avitum AG · 2011
  5. Descendant · cites it directly · 0 of its ownK202508 Hemo-Lyte C CartridgeDi-Chem, Inc. · 2022

Most influential descendants

Showing 2 of 2 · See all
  • K102194Solcart BB. Braun Avitum AG · 2011 · cites it directly1descendant
  • K202508Hemo-Lyte C CartridgeDi-Chem, Inc. · 2022 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K873155Gambro Bicart SystemGambro, Inc.1987—
−1K013724BicartGambro Renal Products2002—
0 (this device)K072760Solcart BB. Braun Medizintechnologie GmbH2008—
+1K102194Solcart BB. Braun Avitum AG2011—
+1K202508Hemo-Lyte C CartridgeDi-Chem, Inc.2022—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201110
202210
FIG. 1 — Lineage of K072760, 1987–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KPO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KPO device

  1. #1 K233159 pureFLOW 402, pureFLOW 400, pureFLOW 406…score 14.5 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K013724Bicart
Summary page 1
…ialysis DEVICE CLASSIFICATION: Hemodialysis system and accessories Class H1,CFR Title 21 § 876.5820 PREDICATE DEVICE: Garnbro BiCari:® (K013724) DESCRIPTION: Solcart B consists of a powder concentrate used to prepare bicarbonate concentrate…
Gambro Renal Products2002—

Also cleared against K013724: 4 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K102194Solcart BB. Braun Avitum AG20111
K202508Hemo-Lyte C CartridgeDi-Chem, Inc.20220

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 3 companies; a new generation was cleared every 14.2 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K102194 (B. Braun Avitum AG, 2011) has gone furthest, with 1 descendant of its own.
  • 4 other devices also cite its predicate K013724.

How does its category compare?

All KPO devices

KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder): FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · KPO

2in 2025

2007: 22008: 22009: 12011: 12012: 22013: 12014: 22015: 12016: 12017: 32018: 22020: 52021: 12022: 22023: 32024: 32025: 22026 (partial year): 2
2007high 5 (2020) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KPO

112in 2024

2017: 192 days median2020: 270 days median2023: 263 days median2024: 112 days median
2007high 270 (2020) · low 112 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KPO

6in 2025

2007: 52008: 22009: 12011: 22012: 102015: 32016: 12017: 12018: 112019: 12020: 312022: 22024: 12025: 62026 (partial year): 9
2007high 31 (2020) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KPO

95in 2025

2007: 52008: 82009: 32010: 1072011: 2232012: 702013: 3,8972014: 15,9162015: 8,3402016: 2402017: 802018: 972019: 792020: 2442021: 632022: 252023: 592024: 2592025: 95
2007high 15,916 (2014) · low 3 (2009)2025

MAUDE reports naming product code KPO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—55
20082—28
20091—13
20100—0107
20111—2223
20122—1070
20131—03,897
20142—015,916
20151—38,340
20161—1240
20173192180
20182—1197
20190—179
2020527031244
20211—063
20222—225
20233263059
202431121259
20252—695
20262—9—

What is it indicated for?

Solcart B is intended for use in bicarbonate hemodialysis for acute and chronic renal failure, or acute intoxication with dialyzable substances.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K072760: Solcart B.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K072760

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026